Results 81 to 90 of about 54,287 (293)

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples   +10 more
wiley   +1 more source

Prescription Drug Abuse

open access: yes, 2018
Prescription drug abuse is an action that portrayed as misuse or overuse of prescription drugs. It is a prevalent problem all over the world. U.S is a particular country that has drug abuse as a serious problem has several different causes of the drug ...
Tian, Jiaxi
core  

Prescription Drug Abuse among Ecstasy Users in Miami

open access: yes, 2006
This study examines the nature, extent and consequences of prescription drug abuse among 143 ecstasy users in Miami. Participants were recruited through nightclub and college campus outreach, and through respondent referrals. Instrumentation included the
Kurtz, Steven P.   +3 more
core   +1 more source

Strengthening Pharmacovigilance Reporting for Withdrawal Reactions to Support Deprescribing

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Pharmacovigilance plays a crucial role in post‐marketing surveillance of medicines and relies on the spontaneous reporting of adverse drug reactions (ADRs). Discontinuation of a drug can cause clinically relevant signs and symptoms, including withdrawal reactions; however, this subset of ADRs is not fully accommodated in current pharmacovigilance ...
Zakir Khan, Frank Moriarty
wiley   +1 more source

Prescription Drug Monitoring Programs and Other Interventions to Combat Prescription Opioid Abuse

open access: yesWestern Journal of Emergency Medicine, 2012
The Center for Disease Control and Prevention (CDC) has published significant data and trendsrelated to opioid prescription pain relievers (OPR). In 2008, 20,044 deaths were attributedto prescription drug overdose of which 14,800 (73.8%) were due to OPR,
Bharath Chakravarthy   +2 more
doaj  

Reducing prescription drug misuse and abuse : a priority for Oregon

open access: yes, 2013
This archived document is maintained by the Oregon State Library as part of the Oregon Documents Depository Program. It is for informational purposes and may not be suitable for legal purposes.Mode of access: Internet from the Oregon Government ...

core  

Elimination Profile of Deflazacort and Metabolites in Urine and Plasma Following Oral Administration: Relevance to Sports Drug Testing

open access: yesDrug Testing and Analysis, EarlyView.
Results confirm that the MRL of 30 ng/mL for 21‐desacetyl‐deflazacort together with a 3‐day washout period is an appropriated strategy to detect oral deflazacort administration in sport competition. ABSTRACT Deflazacort (DEF) is a glucocorticoid prohibited in sports competitions when orally administered.
Sergi Coll   +5 more
wiley   +1 more source

Opioid and benzodiazepine prescription among patients with cirrhosis compared to other forms of chronic disease

open access: yesBMJ Open Gastroenterology, 2019
ObjectiveData on patterns and correlates of opioid and benzodiazepines prescriptions among patients with chronic conditions are limited. Given a diminished capacity for hepatic clearance, patients with cirrhosis represent a high risk group for use.
Monica A Konerman   +8 more
doaj   +1 more source

Policy Brief on National Survey on Alcohol and Drug Abuse among Secondary School Students in Kenya

open access: yes, 2020
This survey on alcohol and substance abuse in Kenyan secondary schools contributes to the growing body of knowledge on the impact of alcohol and drug abuse in the country as a whole and the education sector.
Muteti, John   +2 more
core  

Home - About - Disclaimer - Privacy